Shopping Cart
- Remove All
- Your shopping cart is currently empty
Phenserine tartrate ((-)-Eseroline phenylcarbamate) is a derivative of Physostigmine and functions as an efficient, non-competitive, long-acting, and selective inhibitor of acetylcholinesterase (AChE). This compound reduces the formation of amyloid precursor protein (APP) and β-amyloid peptides (Aβ), potentially improving cognitive abilities and alleviating the progression of Alzheimers disease.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | Phenserine tartrate ((-)-Eseroline phenylcarbamate) is a derivative of Physostigmine and functions as an efficient, non-competitive, long-acting, and selective inhibitor of acetylcholinesterase (AChE). This compound reduces the formation of amyloid precursor protein (APP) and β-amyloid peptides (Aβ), potentially improving cognitive abilities and alleviating the progression of Alzheimers disease. |
In vitro | Phenserine, when administered at concentrations of 1-25 μM for 48 hours to CHO APP 751SW cells, demonstrates significant biological activity. Specifically, CHO APP 751SW cells treated with 10 μM of Phenserine exhibit an 18.6% reduction in cell viability, while a higher concentration of 25 μM results in a 51.4% decrease in APP levels. |
In vivo | When administered intraperitoneally at doses of 1-4 mg/kg for a continuous period of four days, phenserine improves learning in spatial memory tasks where cholinergic function is impaired in male Fischer-344 rats. |
Alias | (-)-Phenserine (+)-tartrate, (-)-Eseroline phenylcarbamate tartrate |
Molecular Weight | 487.5 |
Formula | C24H29N3O8 |
Cas No. | 156910-61-1 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.